Cambridge Trust’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $17.9M | Sell |
138,683
-6,774
| -5% | -$819K | 0.68% | 46 |
|
|
2023
Q4 | $16.6M | Sell |
145,457
-11,358
| -7% | -$1.13M | 0.69% | 52 |
|
|
2023
Q3 | $14.3M | Buy |
156,815
+4,621
| +3% | +$477K | 0.66% | 53 |
|
|
2023
Q2 | $17.1M | Sell |
152,194
-7,398
| -5% | -$782K | 0.78% | 48 |
|
|
2023
Q1 | $16.7M | Sell |
159,592
-59,786
| -27% | -$6.24M | 0.8% | 46 |
|
|
2022
Q4 | $24.3M | Sell |
219,378
-2,152
| -1% | -$226K | 1.09% | 34 |
|
|
2022
Q3 | $19.4M | Sell |
221,530
-48,787
| -18% | -$4.43M | 0.92% | 40 |
|
|
2022
Q2 | $21.1M | Sell |
270,317
-6,796
| -2% | -$561K | 0.93% | 40 |
|
|
2022
Q1 | $23.6M | Buy |
277,113
+6,178
| +2% | +$592K | 0.83% | 43 |
|
|
2021
Q4 | $32.5M | Sell |
270,935
-2,253
| -0.8% | -$280K | 1.05% | 33 |
|
|
2021
Q3 | $33.8M | Buy |
273,188
+359
| +0.1% | +$46.2K | 1.27% | 25 |
|
|
2021
Q2 | $32.7M | Sell |
272,829
-5,654
| -2% | -$646K | 1.23% | 27 |
|
|
2021
Q1 | $29.3M | Buy |
278,483
+4,264
| +2% | +$432K | 1.2% | 30 |
|
|
2020
Q4 | $27.9M | Sell |
274,219
-20,250
| -7% | -$1.9M | 1.32% | 31 |
|
|
2020
Q3 | $24.8M | Sell |
294,469
-3,183
| -1% | -$248K | 1.28% | 31 |
|
|
2020
Q2 | $22M | Sell |
297,652
-10,538
| -3% | -$696K | 1.15% | 33 |
|
|
2020
Q1 | $20.1M | Buy |
308,190
+109,933
| +55% | +$8.66M | 1.38% | 25 |
|
|
2019
Q4 | $15.6M | Sell |
198,257
-73
| -0% | -$5.68K | 0.83% | 44 |
|
|
2019
Q3 | $15.8M | Buy |
198,330
+322
| +0.2% | +$25.3K | 0.92% | 40 |
|
|
2019
Q2 | $16.6M | Buy |
198,008
+4,081
| +2% | +$325K | 0.96% | 39 |
|
|
2019
Q1 | $15.3M | Buy |
193,927
+8,252
| +4% | +$602K | 0.92% | 41 |
|
|
2018
Q4 | $12.4M | Buy |
185,675
+574
| +0.3% | +$39.7K | 0.85% | 43 |
|
|
2018
Q3 | $14.8M | Buy |
185,101
+269
| +0.1% | +$20.1K | 0.85% | 43 |
|
|
2018
Q2 | $12.5M | Sell |
184,832
-611
| -0.3% | -$44.4K | 0.77% | 46 |
|
|
2018
Q1 | $14.3M | Buy |
185,443
+6,960
| +4% | +$515K | 0.91% | 41 |
|
|
2017
Q4 | $12.2M | Buy |
178,483
+5,301
| +3% | +$352K | 0.77% | 44 |
|
|
2017
Q3 | $10.8M | Buy |
173,182
+12,122
| +8% | +$725K | 0.73% | 46 |
|
|
2017
Q2 | $8.93M | Buy |
161,060
+7,178
| +5% | +$374K | 0.62% | 54 |
|
|
2017
Q1 | $7.73M | Buy |
153,882
+59,921
| +64% | +$2.92M | 0.51% | 63 |
|
|
2016
Q4 | $4.65M | Buy |
93,961
+5,618
| +6% | +$285K | 0.33% | 78 |
|
|
2016
Q3 | $4.63M | Buy |
88,343
+10,138
| +13% | +$497K | 0.34% | 79 |
|
|
2016
Q2 | $3.49M | Buy |
78,205
+7,010
| +10% | +$305K | 0.27% | 82 |
|
|
2016
Q1 | $2.91M | Buy |
71,195
+60,350
| +556% | +$2.22M | 0.24% | 84 |
|
|
2015
Q4 | $396K | Buy |
+10,845
| New | +$392K | 0.03% | 159 |
|
Other funds holding XYL
Cambridge Trust's XYL Position: Q1 2024 in Review
Cambridge Trust reduced its Xylem (XYL) stake by 4.7% in Q1 2024, selling an estimated $819K and leaving 138,683 shares worth $17.9M. The position accounts for 0.68% of the portfolio, ranked #46.
Cambridge Trust first reported a position in XYL in Q4 2015 and has held it in 34 quarters since. The position peaked at $33.8M in Q3 2021. 987 funds tracked by Wall St. Rank hold XYL as of Q1 2024.
- Cambridge Trust held 138,683 shares of Xylem worth $17.9M as of Q1 2024.
- Cambridge Trust sold 6,774 Xylem shares in Q1 2024, an estimated $819K.
- Xylem made up 0.68% of Cambridge Trust's portfolio in Q1 2024, its #46 holding.
- Cambridge Trust first reported a position in Xylem in Q4 2015 and has held it in 34 quarters since.
- Cambridge Trust's Xylem position peaked at $33.8M in Q3 2021.
- 987 funds tracked by Wall St. Rank held Xylem as of Q1 2024.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.